These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20602758)

  • 1. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
    Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
    Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
    Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
    Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating M2-like monocytes in patients with breast cancer.
    Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
    Tumour Biol; 2017 Jun; 39(6):1010428317711571. PubMed ID: 28639912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD163
    Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement.
    Mohamed ME; Gamal RM; El-Mokhtar MA; Hassan AT; Abozaid HSM; Ghandour AM; Abdelmoez A Ismail S; A Yousef H; H El-Hakeim E; S Makarem Y; Abdellatif Awad A
    Hum Immunol; 2021 Sep; 82(9):634-639. PubMed ID: 34020830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.
    Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H
    Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated IRF8 in Monocytes and Macrophages of Patients with Systemic Sclerosis May Aggravate the Fibrotic Phenotype.
    Ototake Y; Yamaguchi Y; Asami M; Komitsu N; Akita A; Watanabe T; Kanaoka M; Kurotaki D; Tamura T; Aihara M
    J Invest Dermatol; 2021 Aug; 141(8):1954-1963. PubMed ID: 33705797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma.
    Nishio M; Urakawa N; Shigeoka M; Takase N; Ichihara Y; Arai N; Koma Y; Yokozaki H
    Pathol Int; 2016 Feb; 66(2):83-93. PubMed ID: 26778807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CD14
    Zhang M; Ding L; Wang X; Hou J; Li M; Jiang Y; He X; Cui M; Hu F; Zhang X; Yang J; Guo X; Zhao H; Gao P
    Int Immunopharmacol; 2018 Apr; 57():181-189. PubMed ID: 29518744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
    Bhandari R; Ball MS; Martyanov V; Popovich D; Schaafsma E; Han S; ElTanbouly M; Orzechowski NM; Carns M; Arroyo E; Aren K; Hinchcliff M; Whitfield ML; Pioli PA
    Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages.
    Kräling BM; Maul GG; Jimenez SA
    Pathobiology; 1995; 63(1):48-56. PubMed ID: 7546275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro.
    Nielsen MC; Andersen MN; Møller HJ
    Immunology; 2020 Jan; 159(1):63-74. PubMed ID: 31573680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
    Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
    Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes.
    Maniecki MB; Møller HJ; Moestrup SK; Møller BK
    Immunobiology; 2006; 211(6-8):407-17. PubMed ID: 16920480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-associated macrophages are recruited and differentiated in the neoplastic stroma of oral squamous cell carcinoma.
    Essa AA; Yamazaki M; Maruyama S; Abé T; Babkair H; Raghib AM; Megahed EM; Cheng J; Saku T
    Pathology; 2016 Apr; 48(3):219-27. PubMed ID: 27020496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD206 and CD163 on intermediate CD14
    Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
    Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
    Soldano S; Smith V; Montagna P; Gotelli E; Campitiello R; Pizzorni C; Paolino S; Sulli A; Cere A; Cutolo M
    Arthritis Res Ther; 2024 Mar; 26(1):74. PubMed ID: 38509595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.